Pfizer Reorganizes Internally, Closer To Decision On Splitting Business

05 Aug 2013

• By Wendy Diller and Malcolm Spicer

Consumer health products are grouped with vaccines and oncology drugs in Pfizer’s internal reorganization that takes effect in January 2014. Pfizer’s realignment into three organizations represents a step in the firm’s multi-year deliberation over whether to split its business.

Pfizer Inc. is reorganizing its commercial operations into three business segments led by top executives, grouping consumer health products with vaccines and oncology products, a move broadly in line with plans the firm outlined in discussions over the past two years with analysts.

Beginning Jan. 1, 2014, Pfizer will operate with an Innovative Products Group, responsible for drugs in therapeutic areas that are...